143 related articles for article (PubMed ID: 35718128)
1. HM-chromanone suppresses hepatic glucose production via activation of AMP-activated protein kinase in HepG2 cell.
Park JE; Han JS
Eur J Pharmacol; 2022 Aug; 928():175108. PubMed ID: 35718128
[TBL] [Abstract][Full Text] [Related]
2. An active part of Artemisia sacrorum Ledeb. suppresses gluconeogenesis through AMPK mediated GSK3β and CREB phosphorylation in human HepG2 cells.
Yuan HD; Piao GC
Biosci Biotechnol Biochem; 2011; 75(6):1079-84. PubMed ID: 21670525
[TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rg2 induces orphan nuclear receptor SHP gene expression and inactivates GSK3β via AMP-activated protein kinase to inhibit hepatic glucose production in HepG2 cells.
Yuan HD; Kim DY; Quan HY; Kim SJ; Jung MS; Chung SH
Chem Biol Interact; 2012 Jan; 195(1):35-42. PubMed ID: 22062806
[TBL] [Abstract][Full Text] [Related]
4. HM-chromanone reverses the blockade of insulin signaling induced by high glucose levels in human HepG2 cells.
Park JE; Han JS
Eur J Pharmacol; 2022 Dec; 937():175358. PubMed ID: 36332682
[TBL] [Abstract][Full Text] [Related]
5. AMP-activated protein kinase activation increases phosphorylation of glycogen synthase kinase 3beta and thereby reduces cAMP-responsive element transcriptional activity and phosphoenolpyruvate carboxykinase C gene expression in the liver.
Horike N; Sakoda H; Kushiyama A; Ono H; Fujishiro M; Kamata H; Nishiyama K; Uchijima Y; Kurihara Y; Kurihara H; Asano T
J Biol Chem; 2008 Dec; 283(49):33902-10. PubMed ID: 18801732
[TBL] [Abstract][Full Text] [Related]
6. HM-chromanone from Portulaca oleracea L. inhibits protein tyrosine phosphatase 1B and mitigates glucose production in insulin-resistant HepG2 cells.
Lim HJ; Park JE; Han JS
Fitoterapia; 2023 Jun; 167():105512. PubMed ID: 37080256
[TBL] [Abstract][Full Text] [Related]
7. HM-chromanone, a component of Portulaca oleracea L., stimulates glucose uptake and glycogen synthesis in skeletal muscle cell.
Park JE; Seo Y; Han JS
Phytomedicine; 2021 Mar; 83():153473. PubMed ID: 33513558
[TBL] [Abstract][Full Text] [Related]
8. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.
Lee JM; Seo WY; Song KH; Chanda D; Kim YD; Kim DK; Lee MW; Ryu D; Kim YH; Noh JR; Lee CH; Chiang JY; Koo SH; Choi HS
J Biol Chem; 2010 Oct; 285(42):32182-91. PubMed ID: 20688914
[TBL] [Abstract][Full Text] [Related]
9. HM-Chromanone, a Major Homoisoflavonoid in
Park JE; Han JS
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145191
[TBL] [Abstract][Full Text] [Related]
10. HM-chromanone isolated from
Park JE; Han JS
Toxicol Res (Camb); 2023 Aug; 12(4):648-657. PubMed ID: 37663815
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
12. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
13. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes.
Lee JM; Han HS; Jung YS; Harris RA; Koo SH; Choi HS
J Biol Chem; 2018 Aug; 293(34):13125-13133. PubMed ID: 29950523
[TBL] [Abstract][Full Text] [Related]
14. Selected compounds derived from Moutan Cortex stimulated glucose uptake and glycogen synthesis via AMPK activation in human HepG2 cells.
Ha do T; Trung TN; Hien TT; Dao TT; Yim N; Ngoc TM; Oh WK; Bae K
J Ethnopharmacol; 2010 Sep; 131(2):417-24. PubMed ID: 20633632
[TBL] [Abstract][Full Text] [Related]
15. Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through inhibition of gluconeogenesis and activation of glycogenesis via regulating the AMPK/ FoxO1/AKT/GSK3β signaling cascade.
Ahmed SA; Sarma P; Barge SR; Swargiary D; Devi GS; Borah JC
Chem Biol Interact; 2023 Feb; 371():110347. PubMed ID: 36627075
[TBL] [Abstract][Full Text] [Related]
16. HM-chromanone inhibits adipogenesis by regulating adipogenic transcription factors and AMPK in 3T3-L1 adipocytes.
Je JY; Park JE; Seo Y; Han JS
Eur J Pharmacol; 2021 Feb; 892():173689. PubMed ID: 33127360
[TBL] [Abstract][Full Text] [Related]
17. Casein glycomacropeptide-derived peptide IPPKKNQDKTE ameliorates high glucose-induced insulin resistance in HepG2 cells via activation of AMPK signaling.
Song JJ; Wang Q; Du M; Li TG; Chen B; Mao XY
Mol Nutr Food Res; 2017 Feb; 61(2):. PubMed ID: 27506476
[TBL] [Abstract][Full Text] [Related]
18. Saponarin activates AMPK in a calcium-dependent manner and suppresses gluconeogenesis and increases glucose uptake via phosphorylation of CRTC2 and HDAC5.
Seo WD; Lee JH; Jia Y; Wu C; Lee SJ
Bioorg Med Chem Lett; 2015 Nov; 25(22):5237-42. PubMed ID: 26471090
[TBL] [Abstract][Full Text] [Related]
19. Vernonia amygdalina Delile extract inhibits the hepatic gluconeogenesis through the activation of adenosine-5'monophosph kinase.
Wu XM; Ren T; Liu JF; Liu YJ; Yang LC; Jin X
Biomed Pharmacother; 2018 Jul; 103():1384-1391. PubMed ID: 29864922
[TBL] [Abstract][Full Text] [Related]
20. Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db/db mice.
Li YY; Yu LF; Zhang LN; Qiu BY; Su MB; Wu F; Chen DK; Pang T; Gu M; Zhang W; Ma WP; Jiang HW; Li JY; Nan FJ; Li J
Toxicol Appl Pharmacol; 2013 Dec; 273(2):325-34. PubMed ID: 24055643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]